FDA Inspection 1277227 — Ultragenyx Pharmaceutical Inc.
The FDA completed an inspection of Ultragenyx Pharmaceutical Inc. on Jul 17, 2025 in Novato, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 17, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Novato, CA (United States)